Panther Fusion® GI Expanded Bacterial Assay
A fully-automated approach to gastrointestinal (GI) molecular testing of Yersinia enterocolitica, Vibrio parahaemolyticus, Vibrio vulnificus, Vibrio cholerae, Escherichia coli O157, and Plesiomonas shigelloides.1,2
Accuracy & Flexibility for the Patient & the Lab
With highly sensitive and reliable results,1,2 the Panther Fusion GI Expanded Bacterial assay supports informed clinical decision-making while seamlessly integrating into existing laboratory workflows.
A New Approach to Gastrointestinal Bacterial Testing
The global impact of foodborne disease is substantial with an estimated 600 million people becoming ill, resulting in 420,000 deaths annually.1
Act Fast
Trust more than just instinct. Panther Fusion GI Expanded Bacterial assay delivers the speed and sensitivity to diagnose enteric disease rapidly.2
Accurate
Leverage on accurate diagnostics to guide treatment decisions.1
Relevant
Tailor results2 to deliver what matters to you and your patients.
Simplify & Scale the Future of Diagnostics
The Panther Fusion GI Expanded Bacterial Assay is part of Panther® Scalable Solutions, a portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Proven Performance
Providing high clinical performance and accuracy in gastrointestinal bacterial testing.1 The Panther Fusion GI Expanded Bacterial assay has a very high Positive Percentage Agreement (PPA) and Negative Percentage Agreement (NPA) with clinical comparator, in retrospective samples.1
100% PPA
98.2% NPA
Yersinia spp.
100% PPA
96.5% NPA
Vibrio spp.
100% PPA
99.4% NPA
STEC O157
100% PPA
99.4% NPA
Plesiomonas
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
